The original research group. Biological and medical innovation, and the birthplace of the RT4828 ProtoCell.
Addapa Industries
Facilities
From 1983 through 1996, Addapa Industries expanded its operations across six global facilities, each established on the heels of a breakthrough — in biotechnology, in AI, in genetic experimentation.
Each branch operates under varying degrees of autonomy but remains hardlinked to the centralized AICA system. While their goals differ, the collective mission remains unchanged: evolve beyond the limits of biology through controlled, calculated deviation.
Gene splicing and hybrid variance studies, established after the early ICA and ProtoCell trials.
Particle physics and energy harnessing, redirected from a failed nuclear acquisition.
Robotics and machinery — vessels and mechanisms capable of housing or controlling unstable variants.
Chemical breakdown and the repurposing of synthetic compounds for accelerated cellular mutation.
Astronomical observation and signal analysis, built under repeated construction halts.